A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

Theodore C; Bidault F; Bouvet Forteau N; Abdelatif M; Fizazi K; di Palma M; Wibault P; de Crevoisier R; Laplanche A

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

【24h】

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

机译：奥沙利铂联合吉西他滨（GEMOX）在尿路上皮晚期/转移性移行细胞癌（TCC）患者中的II期单中心研究。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BACKGROUND: The aim of the study was to evaluate the activity and the safety of the gemcitabine-oxaliplatin (GEMOX) combination as first-line treatment in advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. Materials and methods: Patients with metastatic or unresectable TCC, PS

机译：背景：这项研究的目的是评估吉西他滨-奥沙利铂（GEMOX）组合作为尿路上晚期/转移性移行细胞癌（TCC）的一线治疗的活性和安全性。材料和方法：根据RECIST标准，患有转移性或不可切除的TCC，PS

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2006年第6期|共5页
作者
Theodore C; Bidault F; Bouvet Forteau N; Abdelatif M; Fizazi K; di Palma M; Wibault P; de Crevoisier R; Laplanche A;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Metastatic to; oxaliplatin; gemcitabine; Carcinoma; Transitional Cell; 癌; 移行性细胞;

机译：Metastatic to;oxaliplatin;gemcitabine;Carcinoma;Transitional Cell;癌;移行性细胞;

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. [J] . Theodore C, Bidault F, Bouvet Forteau N, Annals of oncology: official journal of the European Society for Medical Oncology . 2006,第6期

机译：奥沙利铂联合吉西他滨（GEMOX）在尿路上皮晚期/转移性移行细胞癌（TCC）患者中的II期单中心研究。
3. 793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients [J] . F.Cappuzzo, S.Novello, F.De Marinis, European Journal of Cancer Supplements . 2003,第5期

机译：793吉西他滨-奥沙利铂（GEMOX）化疗在未经治疗的局部晚期或转移性非小细胞肺癌（NSCLC）患者中的多中心II期研究
4. 793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients [J] . F.Cappuzzo, S.Novello, F.De Marinis, European Journal of Cancer Supplements . 2003,第5期

机译：793吉西他滨-奥沙利铂（GEMOX）化疗在未经治疗的局部晚期或转移性非小细胞肺癌（NSCLC）患者中的多中心II期研究
5. Improved diagnosis and therapy of superficial transitional cell carcinoma (TCC) of the urinary bladder by 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PPIX) fluorescence: a prospective study in 100 patients [C] . Rainer M. Kuntz, Frank Rucker Conference on lasers in surgery: Advanced characterization, therapeutics, and systems XI . 2001

机译：5-氨基乙酰丙酸（5-ALA）诱导的原卟啉IX（PPIX）荧光改善了膀胱浅表移行细胞癌（TCC）的诊断和治疗：一项对100例患者的前瞻性研究
6. Methodological Approaches for Conducting Claims-Based Studies in Patients Diagnosed with Metastatic Renal Cell Carcinoma [D] . Chun, Danielle S. 2021

机译：用于诊断转移性肾细胞癌的患者的基于权利要求的基于权利要求的方法论方法
7. Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987 [O] . Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, -1

机译：在没有事先系统治疗的情况下对局部晚期或转移性尿路上皮癌患者进行的紫杉醇/顺铂/吉西他滨和吉西他滨/顺铂的三期随机对照研究：EORTC组间研究30987
8. Randomized phase III study comparing paclitaxel/cisplatin/ gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC intergroup study 30987 [O] . Bellmunt, J. (Joaquim), Maase, H. (Hans) von der, Mead, G.M. (Graham), 2012

机译：随机三期研究比较了紫杉醇/顺铂/吉西他滨和吉西他滨/顺铂在未经系统治疗的局部晚期或转移性尿路上皮癌患者中的应用：EORTC组间研究30987

A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract.

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅